Cargando…

New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling

Classically, the endocannabinoid system (ECS) consists of endogenous lipids, of which the best known are anandamide (AEA) and 2 arachidonoylglycerol (2-AG), their enzyme machinery for synthesis and degradation and their specific receptors, cannabinoid receptor one (CB1) and cannabinoid receptor two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riquelme-Sandoval, Agustín, de Sá-Ferreira, Caio O., Miyakoshi, Leo M., Hedin-Pereira, Cecilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759141/ https://www.ncbi.nlm.nih.gov/pubmed/33362550 http://dx.doi.org/10.3389/fphar.2020.596572

Ejemplares similares

Antitumor Cannabinoid Chemotypes: Structural Insights
por: Morales, Paula, et al.
Publicado: (2019)

Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
por: Walsh, Kenneth B., et al.
Publicado: (2021)

Cannabinoids and Pain: New Insights From Old Molecules
por: Vučković, Sonja, et al.
Publicado: (2018)

Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
por: Befort, Katia
Publicado: (2015)

Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat
por: Vera, Gema, et al.
Publicado: (2017)

Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives
por: Götz, Marcus R., et al.
Publicado: (2019)

The biosynthesis of the cannabinoids
por: Tahir, M. Nazir, et al.
Publicado: (2021)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
por: Ratano, Patrizia, et al.
Publicado: (2017)

Should oncologists trust cannabinoids?
por: Creanga-Murariu, Ioana, et al.
Publicado: (2023)

Cannabinoid Biosynthesis Using Noncanonical Cannabinoid Synthases
por: Go, Maybelle Kho, et al.
Publicado: (2023)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Emerging Role of (Endo)Cannabinoids in Migraine
por: Leimuranta, Pinja, et al.
Publicado: (2018)

Can Prescribed Cannabinoids Substitute Cannabis?
por: Batalla, A.
Publicado: (2022)

Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
por: Zagzoog, Ayat, et al.
Publicado: (2022)

An α-hemoglobin-derived peptide (m)VD-hemopressin (α) promotes NREM sleep via the CB(1) cannabinoid receptor
por: Xie, Jun-Fan, et al.
Publicado: (2023)

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB(2) Receptors
por: Martínez-Pinilla, Eva, et al.
Publicado: (2017)

Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022)

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
por: Oyagawa, Caitlin R. M., et al.
Publicado: (2018)

Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017)

Targeting the endogenous cannabinoid system to treat neuropathic pain
por: Lau, Benjamin K., et al.
Publicado: (2014)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2016)

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
por: Aso, Ester, et al.
Publicado: (2014)

Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting
por: Rock, Erin M., et al.
Publicado: (2016)

Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
Publicado: (2019)

Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis
por: Rodrigues, Rui S., et al.
Publicado: (2017)

Long-term consequences of adolescent cannabinoid exposure in adult psychopathology
por: Renard, Justine, et al.
Publicado: (2014)

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
por: Ruggiero, Rafael N., et al.
Publicado: (2017)

Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2021)

Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection
por: Vicente-Acosta, Andrés, et al.
Publicado: (2022)

Potential effects of cannabinoids on audiovestibular function: A narrative review
por: Guerra, Joaquin, et al.
Publicado: (2022)

Biological Role of Aldo–Keto Reductases in Retinoic Acid Biosynthesis and Signaling
por: Ruiz, F. Xavier, et al.
Publicado: (2012)

Designing microorganisms for heterologous biosynthesis of cannabinoids
por: Carvalho, Ângela, et al.
Publicado: (2017)

Biosynthesis of Nature-Inspired Unnatural Cannabinoids
por: Lim, Kevin J. H., et al.
Publicado: (2021)

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity
por: Wiskerke, Joost, et al.
Publicado: (2012)

Cannabinoid Signaling Selectively Modulates GABAergic Inhibitory Input to OFF Bipolar Cells in Rat Retina
por: Vielma, Alex H., et al.
Publicado: (2020)

Cannabinoid CB(2) Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease
por: Ruiz de Martín Esteban, Samuel, et al.
Publicado: (2022)

Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
por: Diez-Alarcia, Rebeca, et al.
Publicado: (2016)

Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020)

Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors
por: Finlay, David B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f6b7pubps5656m1ivc9d1es3ml